EVENTIDE ASSET MANAGEMENT LLC 13D and 13G filings for Sutro Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 3:00 pm Sale | 2022-12-31 | 13G | Sutro Biopharma, Inc. STRO | EVENTIDE ASSET MANAGEMENT LLC | 0 0.000% | -2,708,975 (Position Closed) | Filing |
| 2022-02-14 12:00 pm Purchase | 2021-12-31 | 13G | Sutro Biopharma, Inc. STRO | EVENTIDE ASSET MANAGEMENT LLC | 2,708,975 5.900% | 338,000 (+14.26%) | Filing |
| 2021-02-12 4:10 pm Purchase | 2020-12-31 | 13G | Sutro Biopharma, Inc. STRO | EVENTIDE ASSET MANAGEMENT LLC | 2,370,975 5.300% | 1,126,080 (+90.46%) | Filing |